The potential role of catheter-based renal sympathetic denervation in chronic and end-stage kidney disease

Yusuke Sata, Markus P. Schlaich

Research output: Contribution to journalReview ArticleOtherpeer-review

8 Citations (Scopus)


Sympathetic activation is a hallmark of chronic and end-stage renal disease and adversely affects cardiovascular prognosis. Hypertension is present in the vast majority of these patients and plays a key role in the progressive deterioration of renal function and the high rate of cardiovascular events in this patient cohort. Augmentation of renin release, tubular sodium reabsorption, and renal vascular resistance are direct consequences of efferent renal sympathetic nerve stimulation and the major components of neural regulation of renal function. Renal afferent nerve activity directly influences sympathetic outflow to the kidneys and other highly innervated organs involved in blood pressure control via hypothalamic integration. Renal denervation of the kidney has been shown to reduce blood pressure in many experimental models of hypertension. Targeting the renal nerves directly may therefore be specifically useful in patients with chronic and end-stage renal disease. In this review, we will discuss the potential role of catheter-based renal denervation in patients with impaired kidney function and also reflect on the potential impact on other cardiovascular conditions commonly associated with chronic kidney disease such as heart failure and arrhythmias.

Original languageEnglish
Pages (from-to)344-352
Number of pages9
JournalJournal of Cardiovascular Pharmacology and Therapeutics
Issue number4
Publication statusPublished - 2016


  • Denervation
  • Hypertension
  • Renal

Cite this